Arch Venture Partners Ix Overage, L.P.
10% Owner at Lyell Immunopharma, Inc. (LYEL)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-51.7%
vs. S&P 500-61.0%
Beat the market0%
Paper profit on buys−$8.2M
Total bought / sold$12.5M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 9SEC | LYELLyell Immunopharma, Inc. | Buy | 488,0901,426,528 held (+52%) | $25.61 | $12.5M | -66.0% |
- Buy
10% Owner Arch Venture Partners Ix Overage, L.P. bought $12.5M of LYEL at $25.61 — first open-market purchase in our records; raises the stake by 52%.